Shibuya Corporation, a leading Japanese industrial manufacturer, is advancing the field of regenerative medicine by not only offering isolators specifically designed for cell handling, but also by integrating various functional modules to create a "Smart Mass Production Platform for Regenerative Medicine." This platform is adaptable to a wide range of production needs.

In the mass production of regenerative medicine products, bioreactors are commonly used alongside multilayer culture vessels such as 10-layer Cell Factories. These containers are large and heavy, making them difficult to handle. Operations involving such equipment are challenging even in open biosafety cabinets, and even more so within enclosed glovebox systems.

To address this issue, SHIBUYA has developed a dedicated automated transport module for multilayer containers. This module enables the handling of heavy culture vessels within a closed system. It is equipped with a built-in microscope that allows real-time observation of cell conditions, enabling fully automated and aseptic operations in a sealed environment. This significantly enhances both safety and production efficiency.

Additionally, SHIBUYA has introduced the "Regenerative Medicine Integrated Management System," which consolidates environmental monitoring, process control, and electronic standard operating procedures (SOPs). This system enables complete digital management from order placement through to production and shipment, helping to usher the industry into a new era of smart manufacturing.